cn - I have heard from a number of sources that the company gets an event update every week. This has been constant for a couple of years now. As for a Hepa Link buyout I hope that does not happen. We have a limited time to capitalize on our patent protection. I would hate to see the first 3 to 5 years squandered on a learning curve. It would make a lot more sense and dollars to sell to a company that already has a sales team in place worldwide x China, that currently has cardio and diabetes drugs in their lineup. Those relationships are already built and it would simply be an add-on to make their efforts more efficient.

All IMO, dyodd.

tada